IL6 and myeloid sarcoma: Despite further experimental work being required to elucidate the aetio‐pathological significance of these findings, our pathway analysis has unveiled the potential link between the dysregulation of the identified miRNA signature and biological processes highly relevant for MS pathogenesis and DMF efficacy, such as the IL‐6 signaling pathway and the NRF‐2 dependent antioxidant response.